ADMA – Adma Biologics Inc
ADMA — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
11.25
Margin Of Safety %
73
Put/Call OI Ratio
0.24
EPS Next Q Diff
0.03
EPS Last/This Y
0.42
EPS This/Next Y
0.34
Price
9.26
Target Price
30
Analyst Recom
2
Performance Q
-48.64
Upside
126.8%
Beta
0.81
Ticker: ADMA
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | ADMA | 15.81 | 0.63 | 4.82 | 44385 |
| 2026-03-10 | ADMA | 15.8 | 0.63 | 4.59 | 44377 |
| 2026-03-11 | ADMA | 15.66 | 0.66 | 0.81 | 45389 |
| 2026-03-12 | ADMA | 14.99 | 0.66 | 0.62 | 45594 |
| 2026-03-13 | ADMA | 14.99 | 0.66 | 0.65 | 45594 |
| 2026-03-17 | ADMA | 16.15 | 0.46 | 2.44 | 59456 |
| 2026-03-18 | ADMA | 14.86 | 0.47 | 0.02 | 59881 |
| 2026-03-20 | ADMA | 14.34 | 0.37 | 1.12 | 69774 |
| 2026-03-25 | ADMA | 9.6 | 0.36 | 0.72 | 64005 |
| 2026-03-26 | ADMA | 8.29 | 0.29 | 0.23 | 67120 |
| 2026-03-27 | ADMA | 9.25 | 0.27 | 0.22 | 97659 |
| 2026-03-30 | ADMA | 9.15 | 0.23 | 0.24 | 144861 |
| 2026-03-31 | ADMA | 9 | 0.23 | 0.33 | 145251 |
| 2026-04-01 | ADMA | 9.1 | 0.24 | 0.14 | 146569 |
| 2026-04-06 | ADMA | 9.27 | 0.24 | 0.11 | 147281 |
| 2026-04-07 | ADMA | 9.27 | 0.24 | 1.13 | 148144 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | ADMA | 15.81 | - | - | 1.04 |
| 2026-03-10 | ADMA | 15.82 | - | - | 1.04 |
| 2026-03-11 | ADMA | 15.65 | - | - | 1.04 |
| 2026-03-12 | ADMA | 14.99 | - | - | 1.04 |
| 2026-03-13 | ADMA | 15.14 | - | - | 1.04 |
| 2026-03-17 | ADMA | 16.15 | - | - | 1.04 |
| 2026-03-18 | ADMA | 14.86 | - | - | 1.04 |
| 2026-03-19 | ADMA | 15.02 | - | - | 1.04 |
| 2026-03-20 | ADMA | 14.32 | - | - | 1.04 |
| 2026-03-23 | ADMA | 13.59 | - | - | 1.04 |
| 2026-03-24 | ADMA | 11.30 | - | - | 1.04 |
| 2026-03-25 | ADMA | 9.60 | - | - | 1.04 |
| 2026-03-26 | ADMA | 8.28 | - | - | 1.04 |
| 2026-03-27 | ADMA | 9.25 | - | - | 1.04 |
| 2026-03-30 | ADMA | 9.15 | - | - | 1.04 |
| 2026-03-31 | ADMA | 8.99 | - | - | 1.04 |
| 2026-04-01 | ADMA | 9.10 | - | - | 1.04 |
| 2026-04-02 | ADMA | 9.20 | - | - | 1.04 |
| 2026-04-06 | ADMA | 9.27 | - | - | 1.04 |
| 2026-04-07 | ADMA | 9.26 | - | - | 1.04 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | ADMA | -1.05 | 0.34 | 9.17 |
| 2026-03-10 | ADMA | -1.05 | 0.34 | 9.17 |
| 2026-03-11 | ADMA | -1.17 | 0.34 | 8.33 |
| 2026-03-12 | ADMA | -1.17 | 0.34 | 8.33 |
| 2026-03-13 | ADMA | -1.17 | 0.34 | 8.33 |
| 2026-03-18 | ADMA | -1.17 | 0.37 | 8.33 |
| 2026-03-19 | ADMA | -1.17 | 0.37 | 8.33 |
| 2026-03-20 | ADMA | -1.17 | 0.37 | 8.33 |
| 2026-03-23 | ADMA | -1.17 | 0.37 | 8.33 |
| 2026-03-24 | ADMA | -1.17 | 0.37 | 8.33 |
| 2026-03-25 | ADMA | -1.17 | 0.37 | 11.25 |
| 2026-03-26 | ADMA | -1.17 | 0.37 | 11.25 |
| 2026-03-27 | ADMA | -1.17 | 0.37 | 11.25 |
| 2026-03-30 | ADMA | -1.17 | -1.20 | 11.25 |
| 2026-03-31 | ADMA | -1.17 | -1.20 | 11.25 |
| 2026-04-01 | ADMA | -1.17 | -1.20 | 11.25 |
| 2026-04-02 | ADMA | -1.17 | -1.20 | 11.25 |
| 2026-04-06 | ADMA | -1.17 | 0.38 | 11.25 |
| 2026-04-07 | ADMA | -1.17 | 0.38 | 11.25 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.22
Avg. EPS Est. Current Quarter
0.21
Avg. EPS Est. Next Quarter
0.25
Insider Transactions
-1.17
Institutional Transactions
0.38
Beta
0.81
Average Sales Estimate Current Quarter
142
Average Sales Estimate Next Quarter
153
Fair Value
15.99
Quality Score
98
Growth Score
74
Sentiment Score
9
Actual DrawDown %
63.9
Max Drawdown 5-Year %
-66.2
Target Price
30
P/E
15.46
Forward P/E
7.26
PEG
0.21
P/S
4.32
P/B
4.61
P/Free Cash Flow
79.27
EPS
0.6
Average EPS Est. Cur. Y
1.04
EPS Next Y. (Est.)
1.38
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
28.8
Relative Volume
0.68
Return on Equity vs Sector %
3.3
Return on Equity vs Industry %
19.9
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.1
EBIT Estimation
◆
ADMA
Healthcare
$9.26
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
26.6
Range 1M
22.6%
Sup Dist
1.2%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
45.4%
EPS NY
33.5%
52W%
11.2%
Long-Term Value
Quality companies, undervalued
STRONG
🟢 BUY
+277.4% upside
Upside
+277.4%
Quality
98
MoS
73%
ADMA Biologics IncSector: Healthcare
Industry: Biotechnology
Employees: 640
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
ADMA
Latest News
—
Caricamento notizie per ADMA…
stock quote shares ADMA – Adma Biologics Inc Stock Price stock today
news today ADMA – Adma Biologics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ADMA – Adma Biologics Inc yahoo finance google finance
stock history ADMA – Adma Biologics Inc invest stock market
stock prices ADMA premarket after hours
ticker ADMA fair value insiders trading